© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 18, 2022
A discussion on using continuous glucose monitoring systems to improve the management of type 2 diabetes.
The benefits of using new therapies, such as SGLT2 inhibitors and GLP-1 receptor agonists, to treat type 2 diabetes.
January 11, 2022
Takeaways of the most recent ADA guidelines in terms of treating patients with diabetes with metformin, SGLT2 inhibitors, and GLP-1 receptor agonists.
Guidance on the use of aspirin therapy in patients at risk of cardiovascular events, based on recently updated guideline recommendations.